| 0 (0%) | 04-25 04:20 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 19.13 | 1-year : | 20.42 |
| Resists | First : | 16.38 | Second : | 17.48 |
| Pivot price | 15.26 |
|||
| Supports | First : | 14.6 | Second : | 12.14 |
| MAs | MA(5) : | 15.02 |
MA(20) : | 15.52  |
| MA(100) : | 14.81 |
MA(250) : | 13.75 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 34.9 |
D(3) : | 25.9 |
| RSI | RSI(14): 46 |
|||
| 52-week | High : | 17.65 | Low : | 9.63 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MDV ] has closed above bottom band by 43.6%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.26 - 15.33 | 15.33 - 15.4 |
| Low: | 14.81 - 14.9 | 14.9 - 14.98 |
| Close: | 15.04 - 15.17 | 15.17 - 15.3 |
Fri, 12 Jul 2019
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 9 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 10.3 (%) |
| Held by Institutions | 8.3 (%) |
| Shares Short | 11 (K) |
| Shares Short P.Month | 8 (K) |
| EPS | -1.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.75 |
| Profit Margin | -14.1 % |
| Operating Margin | 38 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | -3.8 % |
| Qtrly Rev. Growth | -10.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.14 |
| EBITDA (p.s.) | 2.55 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 17 (M) |
| Levered Free Cash Flow | 23 (M) |
| PE Ratio | -11.17 |
| PEG Ratio | 0 |
| Price to Book value | 0.8 |
| Price to Sales | 2.94 |
| Price to Cash Flow | 8.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|